D2 is a specialised early-stage venture capital fund that invests in business to business software companies.
Portfolio
4
companies
Asterix Health
Remote healthcare platform helping NHS practices manage workforce shortages.
Curvestone AI
Curvestone AI builds reliable workflow automation platforms for regulated industries.
OctaiPipe
OctaiPipe builds an edge AI platform for critical infrastructure industries.
Xapien
Xapien provides an artificial intelligence platform for automated compliance and due diligence research.
Joshua Minsk
LinkedInTriple Point leads the pre-seed round to help the remote healthcare platform expand across NHS practices.
"For the first time in decades, we are actually growing the pie, increasing the number of highly qualified GPs available to deliver primary care rather than simply moving existing GPs around the country. Our early partners are already seeing significant productivity gains and reallocating the saved time into new proactive care services for patients as a result,"
MTech Capital led the seed round with participation from Boost Capital Partners, D2 Fund, and Portfolio Ventures.
"In regulated industries, quality and scale have always been at odds. You can review everything and go broke, or cut corners and hope for the best. AI that actually works changes that equation by handling routine validation at scale while humans focus on the complex cases that need expert judgement."
The pre-Series A round and Innovate UK grant will fund federated learning development and platform scaling.
"Critical Infrastructure is a multi-trillion dollar industry. Across Energy, Utilities and Telecoms – on-device Federated Learning has the potential to improve performance, reduce failures, enhance security and lead to more efficient, more sustainable services. The OctaiPipe team has already demonstrated significant customer traction and we are delighted to support them as they scale to address this important market."
The funding round was led by YFM Equity Partners alongside D2 and existing investors to support international expansion and product development.
"Every year, billions of dollars are wasted on laborious and time-consuming background research."
